Media Summary: Can high-sensitivity C-reactive protein (CRP), low-density lipoprotein (LDL) cholesterol, and lipoprotein(a) levels be used to ... Finerenone is a nonsteroidal mineralocorticoid receptor antagonist. Its physiochemical properties are distinct from those of ... Recent research revealed that giving seniors with heart failure higher doses is beneficial. Dr. Joseph S. Alpert, editor-in-chief of ...
Journal Jam 7 Amiodarone Vs - Detailed Analysis & Overview
Can high-sensitivity C-reactive protein (CRP), low-density lipoprotein (LDL) cholesterol, and lipoprotein(a) levels be used to ... Finerenone is a nonsteroidal mineralocorticoid receptor antagonist. Its physiochemical properties are distinct from those of ... Recent research revealed that giving seniors with heart failure higher doses is beneficial. Dr. Joseph S. Alpert, editor-in-chief of ... NEJM Editorial Fellow Sarah Gorey, MD, summarizes the Original Article “Global Effect of Cardiovascular Risk Factors on Lifetime ... NEJM Editorial Fellow Harleen Marwah, MD, summarizes the API-CAT trial. Read the full trial results: Laurie J. Morrison is interviewed by Toronto ACP Paramedic Martin Johnston. All the questions were submitted by Toronto ...
NEJM Editorial Fellow Abarna Pearl, MD, MPH, summarizes the ZENITH trial. Read the full trial results: You'd think ketamine was in the ED drinking water! Not only has this NMDA receptor antagonist been used effectively for ... Two conditions. Both cause a thick heart. Both can fool you. Most echo readers know apical sparing as the hallmark of cardiac ... References: Ge, ZhenLi, Xiaobo et al. Ticagrelor alone Did you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss ...
